Vilobelimab
Product Specifications
CAS Number
2250440-41-4
Target
SARS-CoV|||Complement System
Related Pathways
Immunology/Inflammation|||Microbiology/Virology
Purity
0.99
Bioactivity
Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1443142-01 0.02 mg (E-Coli)
Recombinant Bungarus multicinctus Neurotoxin BM10-1-like
Ask
View Details MBS1443142-02 0.1 mg (E-Coli)
Recombinant Bungarus multicinctus Neurotoxin BM10-1-like
Ask
View Details